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The discussion about the European regime for processing personaldata is entering a new phase. After the European Commission
had proposed a new General Data Protection Regulation (GDPR) in
2012, the European Parliament proposed a different version in May
2014. The proposal of the European Parliament of the GDPR
restricts processing personal data by requiring informed consent,
regardless of the purpose the data will be used for and regardless
of whether or not privacy enhancing technologies are applied.
Although there are a number of situations where the version of
the European Parliament proposes alternatives, informed consent
seems set to become the default. In this version of the GDPR,
informed consent is not only required for directly identifiable data
with names, addresses or other identifiers of people, such as IP
addresses, but is deemed to be necessary for all data that is not
anonymous. After all, the version of the Parliament distinguishes
only two types of data: personal vs. anonymous. Many comments
have argued how this version could seriously jeopardise (public)
health research.1-3 Informed consent for the use of data in health
research cannot be based on the dichotomy of personal vs.
anonymous data. In spite of the use of privacy enhancing
technologies, data in health research is highly likely to contain
indirectly identifiable variables, simply because of its granularity.
Moreover, data that may identify subjects is needed for research in
children’s diseases (age classes in months) or effects of
environmental exposure (location) to name but a few.
In June 2015 the Council of Ministers, which is the third player in
drafting European Union (EU) legislation, proposed its version of
the GDPR. That version is much more research friendly. Further use
of personal data is not seen as incompatible with the original use for
which data were processed. Broad consent seems to be possible, and
research without consent is left to the legislation of the member
states. The latter is already the case under the existing EU
Directive 95/46/EC which is at the moment the Europe-wide
standard for processing personal data, as a Directive needs to be
implemented into national law. Regulation, such as the proposed
GDPR, would bind governments, corporations and citizens directly
and hence aims to harmonise completely. In the Council’s version,
such harmonisation would not be reached for research with personal
data without consent. Incomplete harmonisation might be
preferable to harmonisation according to the most strict standards.4
With its proposal, the European Parliament ignores the need for
granular data, at least in the first steps of the research and the use of
privacy enhancing technologies in further steps,5 to give us adequate
feedback on our current practices of health care delivery and health
protection. This kind of research contributes to a learning health
care system which, in the European context, is based on the
principles of solidarity, quality and long-term sustainability.
Research based on large-scale registries (with the records of
millions of patients) used, e.g. to determine disease prevalence
would need the informed consent of all individual patients. Such
procedures create biased research, which affects the quality of our
health care systems. Furthermore, the Parliaments’ proposal is
contrary to recent calls to reduce waste in biomedical research
regulation and management 6 and initiatives aiming at responsible
sharing of individual patient data from clinical trials.7 Therefore, the
research community, together with patient organisations, endorsed
the more research friendly approach of the Council, and the website
datasaveslives.eu gives regular updates about their views and the
GDPR discussions.
Yet, representatives of patient organisations, who know what is at
stake if data will not come to their aid or to those after them, might
not be seen as representatives of the average population. Therefore,
we conducted a survey of citizens’ opinions about health research
and the extent to which people would be willing to give researchers
access to their health data. This used a sample of 1500 members of a
panel of citizens (the Dutch Health Care Consumer Panel of the
Netherlands Institute for Health Services Research NIVEL) of
whom 731 responded. Response rates of this panel depend on the
target group and the subject of a questionnaire and may lead up to
70%. Our current response rate is lower, but still in line with
previous surveys of this panel. The responses have been weighted
to represent the Dutch population for age and gender.
Respondents appeared to have a reasonably high degree of trust in
the research community (78%, compared with 92% in medical
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professionals and 46% in the pharmaceutical industry). Most
respondents agreed that scientific health research is very important
(93%). Two-thirds find it a problem when privacy regulations
become more strict and make less scientific health research
possible (23% has no opinion, 13% finds this a problem). At the
same time, one-third find their autonomy in deciding over their
‘own’ health data more important than medical scientific progress
(29% has no opinion, 40% does not agree with this statement).
However, the majority (three-quarters) agree to their health data
being used without informed consent, as long as this data is well
protected and only used for scientific research (12% has no
opinion). In our analysis, respondents with a higher education
seem to have more need to decide over their ‘own’ health data by
themselves. The same applies to respondents with better self-
reported health and younger respondents.
These outcomes seem to be in line with other findings about
patient views about using patient data for health research.8 Our
findings also show that trust is the paramount issue here. There
has not yet been a data breach reported of patient data once safely
in the research domain, and there is quite a number of techniques
how such safety can be reached.5 Yet, what happens behind the
scenes is not enough. It seems to us that much more transparency
and explanation is needed about how the ‘further use’ of patient data
is the driving force of all improvement in health care and
prevention.9 It should also be explained that what patients might
see as ‘their’ data is in fact the result of all previous learning
experiences and investments in the European solidarity based
health care systems.10 These two explanations, next to data safety
in which all researchers have a vested interest, form the ethical basis
of a research exemption from which the European Parliament might
learn as well.
In the following months, the three mentioned players will
negotiate about a final text, the so-called ‘trilogue’. We may hope
that the outcomes of the trilogue will be more nuanced than the
mistaken ‘consent or anonymise dichotomy’9 and will recognise the
need for health research with granular data. After all, the protection
of data in research should be proportional to the risks and benefits
of the use of that data for improvement of health through research.
This will allow future generations to have the same benefits from
health research as past and current generations.
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